Alligator Bioscience Logo

Alligator Bioscience

Develops immuno-oncology antibody drugs to activate the immune system against hard-to-treat cancers.

ATORX | ST

Overview

Corporate Details

ISIN(s):
SE0000767188 (+8 more)
LEI:
549300E15VI0MB7LXV19
Country:
Sweden
Address:
C/O Medicon Village, 223 81 Lund
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Alligator Bioscience is a clinical-stage biotechnology company that develops tumor-directed immuno-oncology antibody drugs. The company specializes in creating antibody-based pharmaceuticals designed to activate the patient's immune system for cancer treatment. Its proprietary technology platform and drug discovery engine support a pipeline of immunotherapies, with a significant focus on the CD40 pathway. A key product in its pipeline is mitazalimab, a CD40 agonist being developed for hard-to-treat cancers, including pancreatic cancer.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-23 08:00
Quarterly Report
Swedish 1.2 MB
2025-10-23 08:00
Quarterly Report
English 1.2 MB
2025-10-22 23:55
Pre-Annual General Meeting Information
Kallelse till extra bolagsstämma i Alligator Bioscience AB
Swedish 93.3 KB
2025-10-22 23:55
Pre-Annual General Meeting Information
Notice of extraordinary general meeting in Alligator Bioscience AB
English 98.5 KB
2025-10-22 23:05
Share Issue/Capital Change
Alligator Bioscience carries out a rights issue of units of approximately SEK 1…
English 114.4 KB
2025-10-22 23:05
Share Issue/Capital Change
Alligator Bioscience genomför en företrädesemission av units om cirka 120 MSEK …
Swedish 113.8 KB
2025-10-17 09:50
Major Shareholding Notification
Swedish 10.5 KB
2025-10-14 11:07
Major Shareholding Notification
Swedish 10.9 KB
2025-10-13 11:43
Major Shareholding Notification
Swedish 9.6 KB
2025-10-09 11:42
Major Shareholding Notification
Swedish 10.9 KB
2025-10-06 10:45
Major Shareholding Notification
Swedish 10.9 KB
2025-10-03 10:45
Major Shareholding Notification
Swedish 10.9 KB
2025-10-01 09:40
Major Shareholding Notification
Swedish 10.1 KB
2025-09-30 15:00
Declaration of Voting Results & Voting Rights Announcements
Change in number of shares and votes in Alligator Bioscience AB
English 54.8 KB
2025-09-30 15:00
Declaration of Voting Results & Voting Rights Announcements
Ändring av antalet aktier och röster i Alligator Bioscience AB
Swedish 55.3 KB

Automate Your Workflow. Get a real-time feed of all Alligator Bioscience filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Alligator Bioscience

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Alligator Bioscience via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-02-28 Peter Ostler Other Sell 1,658,134 179,045.31 SEK
2024-04-11 Staffan Encrantz Other Sell 44,108,581 47,196,181.67 SEK
2022-10-27 Sören Bregenholt Frederiksen Other Buy 52,000 72,748.00 SEK
2022-10-25 Marie Svensson Other Buy 12,000 16,632.00 SEK
2022-08-19 Sören Bregenholt Frederiksen Other Buy 13,906 25,726.10 SEK
2022-08-18 Sören Bregenholt Frederiksen Other Buy 31,094 56,911.35 SEK
2022-05-31 Peter Ostler Other Buy 100,000 151,500.00 SEK
2022-05-04 Sören Bregenholt Frederiksen Other Buy 30,000 50,895.00 SEK
2022-05-02 Sören Bregenholt Frederiksen Other Buy 30,000 50,811.00 SEK
2022-04-30 Sören Bregenholt Frederiksen Other Buy 30,000 51,171.00 SEK

Peer Companies

Company Country Ticker View
BioPorto Logo
IVD company developing NGAL biomarkers for early acute kidney injury (AKI) risk assessment.
Denmark BIOPOR
Biosergen AB Logo
Developing novel antifungal drugs for life-threatening infections in immunocompromised patients.
Sweden BIOSGN
Bio Solution Co.,Ltd. Logo
Develops cell therapies for degenerative diseases and supplies bio-lab reagents for R&D.
South Korea 086820
Biosynex Logo
European manufacturer of rapid diagnostic tests for professionals and consumer self-tests.
France ALBIO
Biotest AG Logo
Develops plasma protein products & biotherapeutics for immunology, haematology & intensive care.
Germany BIO3
Biotika A.S. Logo
Biotech firm making penicillin & polymyxin B APIs for human/vet use, plus contract manufacturing.
Slovakia BSL
Bioton S.A. Logo
Develops and manufactures recombinant human insulin for global diabetes care solutions.
Poland BIO
BIOVENTIX PLC Logo
Develops high-affinity sheep monoclonal antibodies for global clinical diagnostic immunoassays.
United Kingdom BVXP
Bioversys N Logo
Develops novel therapeutics to combat antimicrobial resistance in life-threatening infections.
Switzerland BIOV
Biovica International B Logo
Develops blood tests to monitor the efficacy of solid tumor cancer therapies.
Sweden BIOVIC

Talk to a Data Expert

Have a question? We'll get back to you promptly.